PURETECH FOUNDED ENTITY VEDANTA BIOSCIENCES ANNOUNCES PHASE 2 STUDY OF VE202 IN ULCERATIVE COLITIS DID NOT MEET PRIMARY ENDPOINT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.